Exact Mass: 480.2359
Exact Mass Matches: 480.2359
Found 500 metabolites which its exact mass value is equals to given mass value 480.2359
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-Hexanoylneosolaniol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins 8-Hexanoylneosolaniol is from Fusarium sporotrichioides. From Fusarium sporotrichioides
4-Propanoyl-HT2 toxin
4-Propanoyl-HT2 toxin is from Fusarium sporotrichioide From Fusarium sporotrichioides
11-Oxo-androsterone glucuronide
11-oxo-androsterone glucuronide is a natural human metabolite of 11-oxo-androsterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
11-Deacetylvaltrate 11-(3-hydroxy-3-methylbutanoate)
11-Deacetylvaltrate 11-(3-hydroxy-3-methylbutanoate) is found in fats and oils. 11-Deacetylvaltrate 11-(3-hydroxy-3-methylbutanoate) is a constituent of Valeriana sp. Constituent of Valeriana species 11-Deacetylvaltrate 11-(3-hydroxy-3-methylbutanoate) is found in tea, fats and oils, and herbs and spices.
Copanlisib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
3-[4-[(E)-2-[6-(Dibutylamino)naphthalen-2-yl]ethenyl]pyridin-1-ium-1-yl]propane-1-sulfonate
Cardivin A
A germacranolide isolated from the aerial parts of Carpesium divaricatum. It exhibits cytotoxicity against the human tumor cells, A-549 (nonsmall cell lung), SK-OV-3 (ovary), SK-MEL-2 (skin), XF-498 (central nervous system) and HCT-15 (colon).
8beta-angeloyloxy-9alpha-(2-methylbutanoyl)-ternifolin
9-isobutyryloxy-15-hydroxy-4beta,15-dihydrorepandanolide-8-O-epoxyangelate
(11alpha,12beta,13S,16alpha)-12,13-bis(acetoxy)-11,16-dihydroxy-2-methoxypicras-2-ene-1,12-dione|picraqualide E
2alpha,5-epoxy-5,10-dihydroxy-6alpha-angeloyloxy-9beta-(3-methylbutyroyloxy)-germacr-11(13)-en-8alpha,12-olide
12alpha-methoxyl-5alpha,14beta-dihydroxy-1alpha,2alpha-diacetoxycass-13(15)-en-16,12-olide|neocaesalpin AA
8-hydroxy-1,10,11-triisovalerylvaltrate hydrine|patriheterdoid C
Ala Tyr Ile Asp
Tyr Val Ala Glu
Ser Phe Ile Asp
Thr Val Phe Asp
Ala Asp Ile Tyr
Ala Asp Leu Tyr
Ala Asp Tyr Ile
Ala Asp Tyr Leu
Ala Glu Val Tyr
Ala Glu Tyr Val
Ala Phe Phe Pro
Ala Phe Ile Met
Ala Phe Leu Met
Ala Phe Met Ile
Ala Phe Met Leu
Ala Phe Pro Phe
Ala Ile Asp Tyr
Ala Ile Phe Met
Ala Ile Met Phe
Ala Ile Tyr Asp
Ala Leu Asp Tyr
Ala Leu Phe Met
Ala Leu Met Phe
Ala Leu Tyr Asp
Ala Met Phe Ile
Ala Met Phe Leu
Ala Met Ile Phe
Ala Met Leu Phe
Ala Pro Phe Phe
Ala Val Glu Tyr
Ala Val Tyr Glu
Ala Tyr Asp Ile
Ala Tyr Asp Leu
Ala Tyr Glu Val
Ala Tyr Leu Asp
Ala Tyr Val Glu
Cys Phe Ile Val
Cys Phe Leu Val
Cys Phe Val Ile
Cys Phe Val Leu
Cys Ile Phe Val
Cys Ile Val Phe
Cys Leu Phe Val
Cys Leu Val Phe
Cys Val Phe Ile
Cys Val Phe Leu
Cys Val Ile Phe
Cys Val Leu Phe
Asp Ala Ile Tyr
Asp Ala Leu Tyr
Asp Ala Tyr Ile
Asp Ala Tyr Leu
Asp Phe Ile Ser
Asp Phe Leu Ser
Asp Phe Ser Ile
Asp Phe Ser Leu
Asp Phe Thr Val
Asp Phe Val Thr
Asp His Ile Pro
Asp His Leu Pro
Asp His Pro Ile
Asp His Pro Leu
Asp Ile Ala Tyr
Asp Ile Phe Ser
Asp Ile His Pro
Asp Ile Pro His
Asp Ile Ser Phe
Asp Ile Tyr Ala
Asp Leu Ala Tyr
Asp Leu Phe Ser
Asp Leu His Pro
Asp Leu Pro His
Asp Leu Ser Phe
Asp Leu Tyr Ala
Asp Pro His Ile
Asp Pro His Leu
Asp Pro Ile His
Asp Pro Leu His
Asp Ser Phe Ile
Asp Ser Phe Leu
Asp Ser Ile Phe
Asp Ser Leu Phe
Asp Thr Phe Val
Asp Thr Val Phe
Asp Val Phe Thr
Asp Val Thr Phe
Asp Tyr Ala Ile
Asp Tyr Ala Leu
Asp Tyr Ile Ala
Asp Tyr Leu Ala
Glu Ala Val Tyr
Glu Ala Tyr Val
Glu Phe Ser Val
Glu Phe Val Ser
Glu Gly Ile Tyr
Glu Gly Leu Tyr
Glu Gly Tyr Ile
Glu Gly Tyr Leu
Glu His Pro Val
Glu His Val Pro
Glu Ile Gly Tyr
Glu Ile Tyr Gly
Glu Leu Gly Tyr
Glu Leu Tyr Gly
Glu Pro His Val
Glu Pro Val His
Glu Ser Phe Val
Glu Ser Val Phe
Glu Val Ala Tyr
Glu Val Phe Ser
Glu Val His Pro
Glu Val Pro His
Glu Val Ser Phe
Glu Val Tyr Ala
Glu Tyr Ala Val
Glu Tyr Gly Ile
Glu Tyr Gly Leu
Glu Tyr Ile Gly
Glu Tyr Leu Gly
Glu Tyr Val Ala
Phe Ala Phe Pro
Phe Ala Ile Met
Phe Ala Leu Met
Phe Ala Met Ile
Phe Ala Met Leu
Phe Ala Pro Phe
Phe Cys Ile Val
Phe Cys Leu Val
Phe Cys Val Ile
Phe Cys Val Leu
Phe Asp Ile Ser
Phe Asp Leu Ser
Phe Asp Ser Ile
Phe Asp Ser Leu
Phe Asp Thr Val
Phe Asp Val Thr
Phe Glu Ser Val
Phe Glu Val Ser
Phe Phe Ala Pro
Phe Phe Pro Ala
Phe Ile Ala Met
Phe Ile Cys Val
Phe Ile Asp Ser
Phe Ile Met Ala
Phe Ile Ser Asp
Phe Ile Val Cys
Phe Leu Ala Met
Phe Leu Cys Val
Phe Leu Asp Ser
Phe Leu Met Ala
Phe Leu Ser Asp
Phe Leu Val Cys
Phe Met Ala Ile
Phe Met Ala Leu
Phe Met Ile Ala
Phe Met Leu Ala
Phe Pro Ala Phe
Phe Pro Phe Ala
Phe Ser Asp Ile
Phe Ser Asp Leu
Phe Ser Glu Val
Phe Ser Ile Asp
Phe Ser Leu Asp
Phe Ser Val Glu
Phe Thr Asp Val
Phe Val Cys Ile
Phe Val Cys Leu
Phe Val Ile Cys
Phe Val Leu Cys
Gly Glu Leu Tyr
Gly Glu Tyr Ile
Gly Glu Tyr Leu
Gly Ile Glu Tyr
Gly Ile Tyr Glu
Gly Lys Asn Tyr
Gly Lys Tyr Asn
Gly Leu Glu Tyr
Gly Asn Lys Tyr
Gly Asn Tyr Lys
Gly Tyr Glu Ile
Gly Tyr Glu Leu
Gly Tyr Ile Glu
Gly Tyr Lys Asn
Gly Tyr Leu Glu
Gly Tyr Asn Lys
His Asp Ile Pro
His Asp Leu Pro
His Asp Pro Ile
His Asp Pro Leu
His Glu Pro Val
His Glu Val Pro
His Ile Asp Pro
His Ile Pro Asp
His Leu Asp Pro
His Leu Pro Asp
His Pro Asp Ile
His Pro Asp Leu
His Pro Glu Val
His Pro Ile Asp
His Pro Leu Asp
His Pro Val Glu
His Val Glu Pro
His Val Pro Glu
Ile Ala Asp Tyr
Ile Ala Phe Met
Ile Ala Met Phe
Ile Ala Tyr Asp
Ile Cys Phe Val
Ile Cys Val Phe
Ile Asp Ala Tyr
Ile Asp Phe Ser
Ile Asp His Pro
Ile Asp Pro His
Ile Asp Ser Phe
Ile Asp Tyr Ala
Ile Glu Gly Tyr
Ile Glu Tyr Gly
Ile Phe Ala Met
Ile Phe Cys Val
Ile Phe Asp Ser
Ile Phe Met Ala
Ile Phe Ser Asp
Ile Phe Val Cys
Ile Gly Glu Tyr
Ile Gly Tyr Glu
Ile His Asp Pro
Ile His Pro Asp
Ile Met Ala Phe
Ile Met Phe Ala
Ile Pro Asp His
Ile Pro His Asp
Ile Ser Asp Phe
Ile Val Cys Phe
Ile Val Phe Cys
Lys Gly Asn Tyr
Lys Gly Tyr Asn
Lys Asn Gly Tyr
Lys Asn Tyr Gly
Lys Tyr Gly Asn
Lys Tyr Asn Gly
Leu Ala Phe Met
Leu Ala Met Phe
Leu Cys Phe Val
Leu Cys Val Phe
Leu Asp His Pro
Leu Asp Pro His
Leu Phe Ala Met
Leu Phe Cys Val
Leu Phe Met Ala
Leu Phe Val Cys
Leu His Asp Pro
Leu His Pro Asp
Leu Met Ala Phe
Leu Met Phe Ala
Leu Pro Asp His
Leu Pro His Asp
Leu Val Cys Phe
Leu Val Phe Cys
Met Ala Phe Ile
Met Ala Phe Leu
Met Ala Ile Phe
Met Ala Leu Phe
Met Phe Ala Ile
Met Phe Ala Leu
Met Phe Ile Ala
Met Phe Leu Ala
Met Ile Ala Phe
Met Ile Phe Ala
Met Leu Ala Phe
Met Leu Phe Ala
Asn Gly Lys Tyr
Asn Gly Tyr Lys
Asn Lys Gly Tyr
Asn Lys Tyr Gly
Asn Tyr Gly Lys
Asn Tyr Lys Gly
Pro Ala Phe Phe
Pro Asp His Ile
Pro Asp His Leu
Pro Asp Ile His
Pro Asp Leu His
Pro Glu His Val
Pro Glu Val His
Pro Phe Ala Phe
Pro Phe Phe Ala
Pro His Asp Ile
Pro His Asp Leu
Pro His Glu Val
Pro His Ile Asp
Pro His Leu Asp
Pro His Val Glu
Pro Ile Asp His
Pro Ile His Asp
Pro Leu Asp His
Pro Leu His Asp
Pro Val Glu His
Pro Val His Glu
Val Cys Phe Ile
Val Cys Phe Leu
Val Cys Ile Phe
Val Cys Leu Phe
Val Glu His Pro
Val Glu Pro His
Val Phe Cys Ile
Val Phe Cys Leu
Val Phe Ile Cys
Val Phe Leu Cys
Val His Glu Pro
Val His Pro Glu
Val Ile Cys Phe
Val Ile Phe Cys
Val Leu Cys Phe
Val Leu Phe Cys
Val Pro Glu His
Val Pro His Glu
Tyr Ala Ile Asp
Tyr Ala Leu Asp
Tyr Gly Lys Asn
Tyr Gly Asn Lys
Tyr Lys Gly Asn
Tyr Lys Asn Gly
Tyr Asn Gly Lys
Tyr Asn Lys Gly
11-Deacetylvaltrate 11-(3-hydroxy-3-methylbutanoate)
4-Propanoyl-HT2 toxin
8-Hexanoylneosolaniol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Di-4-ANEPPS
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
Hydrocortisone succinate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000893 - Anti-Inflammatory Agents
solifenacin succinate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Solifenacin Succinate (YM905) is a novel muscarinic receptor antagonist with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.
(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate
Copanlisib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Ethyl 2-(4-methoxyphenyl)-5-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]pyrazolo[1,5-a]pyrimidine-6-carboxylate
N-[[(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
2-[(1R,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
2-[(2S,4aS,12aS)-8-(benzylcarbamoylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
N-[[(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
2-[(1S,3S,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-(cyclopentylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
2-[(2S,4aR,12aS)-8-(benzylcarbamoylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
2-[(1R,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
2-[(2R,4aR,12aR)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
2-[(1S,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-pyridin-4-ylacetamide
2-[(2R,4aS,12aR)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[[oxo-[(phenylmethyl)amino]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide
hydrogen (2Z)-but-2-enedioate (6-methyl-9,10-didehydroergolin-8beta-yl)methyl cyclohexanecarboxylate (1:1:1)
5-HT4 antagonist 1
5-HT4 antagonist 1 is a 5-HT4 receptor antagonist with a pKi of 9.6.
(1s,2s,3r,7r,8s,9r,11r,13s)-1,9-dihydroxy-9,13-dimethyl-8-[(3-methylbutanoyl)oxy]-4-methylidene-5-oxo-6,14-dioxatricyclo[9.2.1.0³,⁷]tetradecan-2-yl (2z)-2-methylbut-2-enoate
[3-(acetyloxy)-9,10-dihydroxy-6-(methoxymethyl)-12-methyl-7-oxo-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-12-yl]methyl acetate
(3ar,4s,6s,8s,10r,11s,11ar)-8,10-dihydroxy-6,10-dimethyl-11-{[(2r)-2-methylbutanoyl]oxy}-3-methylidene-2,5-dioxo-octahydrocyclodeca[b]furan-4-yl (2z)-2-methylbut-2-enoate
(1r,2s,3r,7r,8s,9r,11s,13s)-1,9-dihydroxy-9,13-dimethyl-8-{[(2r)-2-methylbutanoyl]oxy}-4-methylidene-5-oxo-6,14-dioxatricyclo[9.2.1.0³,⁷]tetradecan-2-yl (2z)-2-methylbut-2-enoate
(3as,4s,5r,6r,9r,10r,11ar)-6,9-dihydroxy-6,10-dimethyl-5-{[(2r)-2-methylbutanoyl]oxy}-3-methylidene-2,7-dioxo-octahydrocyclodeca[b]furan-4-yl (2z)-2-methylbut-2-enoate
(3r,6r,9r)-2,8,11-trihydroxy-3-[(s)-hydroxy(phenyl)methyl]-4,9-dimethyl-6-(sec-butyl)-6,9-dihydro-3h-1,4,7,10-benzotetrazacyclotridecin-5-one
(5s)-9-methoxy-2-({9-methoxy-3,5-dimethylnaphtho[2,3-b]furan-4-yl}methyl)-3,4,5-trimethyl-5h,6h-naphtho[2,3-b]furan
(1's,2r,2'r,4's,7'r,9'r,10'r,11's)-11'-(acetyloxy)-2'-[(acetyloxy)methyl]-10'-hydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-4'-yl hexanoate
(1r,2s,3r,6r,8s,11s,12s,13r,14r,15r,16r,17s)-11,12,15,16-tetrahydroxy-9,13,17-trimethyl-4-oxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-en-3-yl (2r)-2-methylbutanoate
2,5-epoxy-5,10-dihydroxy-6-angeloyloxy-9-(2-methylbutyryloxy)-germacran-8,12-olide
{"Ingredient_id": "HBIN004670","Ingredient_name": "2,5-epoxy-5,10-dihydroxy-6-angeloyloxy-9-(2-methylbutyryloxy)-germacran-8,12-olide","Alias": "NA","Ingredient_formula": "C25H36O9","Ingredient_Smile": "CCC(C)C(=O)OC1C2C(C(C3(C(CC(O3)CC1(C)O)C)O)OC(=O)C(=CC)C)C(=C)C(=O)O2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7073","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,5-epoxy-5,10-dihydroxy-6-angeloyloxy-9-(2r-methylbutyryloxy)-germacran-8,12-olide
{"Ingredient_id": "HBIN004671","Ingredient_name": "2,5-epoxy-5,10-dihydroxy-6-angeloyloxy-9-(2r-methylbutyryloxy)-germacran-8,12-olide","Alias": "NA","Ingredient_formula": "C25H36O9","Ingredient_Smile": "CCC(C)C(=O)OC1C2C(C(C3(C(CC(O3)CC1(C)O)C)O)OC(=O)C(=CC)C)C(=C)C(=O)O2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7074","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,5-epoxy-5,10-dihydroxy-6-angeloyloxy-9-(3-methylbutyryloxy)-germacran-8,12-olide
{"Ingredient_id": "HBIN004672","Ingredient_name": "2,5-epoxy-5,10-dihydroxy-6-angeloyloxy-9-(3-methylbutyryloxy)-germacran-8,12-olide","Alias": "NA","Ingredient_formula": "C25H36O9","Ingredient_Smile": "CC=C(C)C(=O)OC1C2C(C(C(CC3CC(C1(O3)O)C)(C)O)OC(=O)CC(C)C)OC(=O)C2=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7075","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}